Caveats against an improper use of hair testing to support the diagnosis of chronic excessive alcohol consumption, following the ' Consensus' of the Society of Hair Testing 2009 [Forensic Science International 196 (2010) 2]

Forensic Science International

Volumn 207, Issue 1-3, 2011, Pages

  Tagliaro, Franco ^a   Bortolotti, Federica ^a   Viel, Guido ^b   Ferrara, Santo Davide ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ETHYL GLUCURONIDE; FATTY ACID ESTER;

ALCOHOL CONSUMPTION; ALCOHOLISM; ENZYME ACTIVITY; FORENSIC IDENTIFICATION; FORENSIC TOXICOLOGY; HAIR ANALYSIS; HAIR LEVEL; HUMAN; LETTER; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

EID: 79953030280     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2010.10.005     Document Type: Letter

References (16)

1. Skopp G., Schmitt G., Potsch L., Dronner P., Aderjan R., Mattern R. Ethylglucuronide in human hair. Alcohol Alcohol. 2000, 35:283-285.
2. Alt A., Janda I., Seidl S., Wurst F.M. Determination of ethyl glucuronide in hair samples. Alcohol Alcohol. 2000, 35:313-314.
3. Auwarter V., Sporkert F., Hartwig S., Pragst F., Vater H., Diefenbacher A. Fatty acid ethyòl esters in hair as markers of alcohol consumption. Segmental hair analysis of alcoholics, social drinkers and teetotalers. Clin. Chem. 2001, 47:2114-2123.
4. Pragst F., Auwarter V., Sporkert F., Spiegel K. Analysis of fatty acid ethyl esters in hair as possible markers of chronically elevated alcohol consumption by7 headspace solid-phase microextraction (HS-SPME) and gas chromatography-mass spectrometry (GC-MS). Forensic Sci. Int. 2001, 121:76-88.
5. Janda I., Weinmann W., Kuehnle T., Lahode M., Alt A. Determination of ethyl glucuronide in human hair by SPE and LC-MS/MS. Forensic Sci. Int. 2002, 128:59-65.
6. Hartwig S., Auwarter V., Pragst F. Fatty acid ethyl esters in scalp, pubic, axillary, beard and body hair as markers for alcohol misuse. Alcohol Alcohol. 2003, 38:163-167.
7. Yegles M, Labarthe A., Auwarter V., Hartwig S., Vater H., wennig R., Pragsts F. Comparison of ethylglucuronide and fatty acid ethil esters concentrations in hair of alcoholics, social drinkers and teetotalers. Forensic Sci. Int. 2004, 145:167-173.
8. Auwarter V., Kiessling B., Pragst F. Squalene in hair - a natural reference substance for the improved interpretation of fatty acid ethil esters concentrations with respect to alcohol misuse. Forensic Sci. Int. 2004, 145:149-159.
9. Politi L., Morini L., Leone F., Polettini A. Ethyl glucuronide in hair: i sit a reliable marker of chronic high levels of alcohol consumption?. Addiction 2006, 101:1408-1412.
10. Wurst F.M., Dursteler-Mac Farland K.M., Auwarter V., ergovic S., Thon N., Yegle M., Halter C., Weinmann W., Wiesbeck G. Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self reports. Alcohol. Clin. Exp. Res. 2008, 32:1552-1557.
11. Kintz P., Villain M., Vallet E., Etter M., Salquebre G., Cirimele V. Ethylglucuronide: unusual distribution between head hair and pubic hair. Forensic Sci. Int. 2008, 176:87-90.
12. Morini L., Politi L., Polettini A. Ethylglucuronide in hair. A sensitive and specific marker of chronic heavy drinking. Addiction 2009, 104:915-920.
13. Determination of ethyl-glucuronide in hair for heavy drinking detection using liquid chromatography-tandem mass spectrometry following solid-phase extraction, Anal. Bional. Chem. 394 (2009) 1895-1901.
14. Morini L., Zucchella A., Polettini A., Politi L., Groppi A. Effect of bleaching on ethyl glucuronide in hair: a in vitro experiment. Forensic Sci. Int. 2010, 198:23-27.
15. Pragst F., Rothe M., Moench B., Hastedt M., Herre S., Simmert D. Combined use of fatty acid ethyl esters and ethyl glucuronide in hair for diagnosis of alcohol abuse: interpretation and advantages. Forensic Sci. Int. 2010, 196:101-110.
16. Schummer C., Appenzeller B.M., Wennig R. Quantitative determination of ethyl glucuronide in sweat. Ther. Drug Monit. 2008, 30:536-539.